Amalgamated Bank’s CytRx Corp CYTR Stock Holding History

Amalgamated Bank’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2,142	Closed	-$6K	–	1627
2017 Q1	$6K	Buy	2,142 +155	+8%	+$392	﹤0.01%	1502
2016 Q4	$4K	Buy	+1,987	New	+$5.84K	﹤0.01%	1514

Other funds holding CYTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Amalgamated Bank's CYTR Position: Q2 2017 in Review

Amalgamated Bank sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 2,142 shares — an estimated $6K sold.

Amalgamated Bank first reported a position in CYTR in Q4 2016 and held it in 2 quarters. The position peaked at $6K in Q1 2017. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

Amalgamated Bank reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
Amalgamated Bank sold 2,142 CytRx Corp shares in Q2 2017, an estimated $6K.
Amalgamated Bank first reported a position in CytRx Corp in Q4 2016 and held it in 2 quarters.
Amalgamated Bank's CytRx Corp position peaked at $6K in Q1 2017.
54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on Amalgamated Bank's 13F filing for Q2 2017, filed 11 Aug 2017.